Asahi Kasei Pharma Denmark A/S: Financial statements 2024
CVR: 40948074
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
Asahi Kasei Pharma Denmark A/S (CVR 40948074) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -757,973 and a net result of DKK 25,492,949 compared with DKK 18,232,738 the year before. Equity in the 2024 report amounted to DKK 951,385,568. The solvency ratio was 99.4%.
- Gross Profit
- DKK -757,973
- Profit/Loss
- DKK 25,492,949
- Equity
- DKK 951,385,568
- Total Assets
- DKK 957,054,116
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -758K | 25.5M | 951.4M | 0 |
| 2023 | - | -941K | 18.2M | 925.9M | 0 |
| 2022 | - | -1.2M | 4.7M | 907.7M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Asahi Kasei Pharma Denmark A/S
Asahi Kasei Pharma Denmark A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named River Forest A/S. The management consists of Daisuke Matsuo. The board consists of Masaya Etoh (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -793,488 and a net result of DKK 25,833,192 compared with DKK 26,072,771 the year before. Equity in the 2026 report amounted to DKK 1,003,291,531.
